TheNexus.Health: Virtual Forum

Hospital Forum on
Getting Patients Back in for Treatment

March 31, 2021 | 1:30 pm Eastern
Vice President, Segmedica Inc.

Peter Simpson

Fifty one years of business experience have taken Peter all over the globe. He has lived and worked in the US, UK and Belgium. He has operated in most of the world’s major markets, including Japan, China and all of Europe with most of his career being spent in the Specialty Chemical, Pharmaceutical, Medical Device and Biotechnology areas. His experiences have included the General Manager of major global businesses, CFO of several companies, Strategic Planning Executive for businesses up to $2.5BN of revenue, as well as acquisitions and divestments, all within the precursor units of AstraZeneca. He is a member of the Royal Institute of Chartered Management Accountants.

He has been Director of Marketing at Life Technologies Inc., a global supplier to the Biotechnology and Biopharmaceutical industry and Vice President of Consulting and Market Research at Lowe Healthcare, at the time one of the world’s largest medical advertising agencies.

His client experience includes AstraZeneca, Johnson and Johnson, GSK, BMS, Boston Scientific, Medtronic, Pfizer, Merck, BlueCross Blue Shield, Roswell Park Cancer Institute, ConAgra, the American Medical Association, the Center for Disease Control, Nestle and many more leading companies.

Peter’s skills include strategic planning processes, branding issues, market segmentation and healthcare marketing and innovative market research. In over two decades of consulting with the healthcare industry he has conducted numerous research projects of all types and is an experienced interviewer and facilitator. He has been researching and developing psychology based methodologies for medical market research for twelve years and has developed a number of novel techniques and processes. He is also a frequent speaker on US Healthcare Policy, markets and development.

A frequent keynote speaker he has been in demand for both client company and public conferences.



Follow Peter